Scientists at the Ineos Oxford Institute (IOI) have found a new potential combination therapy to combat antimicrobial resistance (AMR) by targeting two key bacterial enzymes involved in resistance.
Novel triple drug combination effective against antibiotic-resistant bacteria
Posted in biotech/medical